Robert Mashal's most recent trade in Nuvation Bio Inc - Ordinary Shares - Class A was a trade of 292,983 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 21, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Nuvation Bio Inc - Ordinar... | Robert Mashal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 292,983 | 292,983 | - | - | Stock Option (Right to Buy) | |
Nuvation Bio Inc - Ordinar... | Robert Mashal | Director | Purchase of securities on an exchange or from another person at price $ 1.67 per share. | 01 Apr 2025 | 98,900 | 200,000 | - | 1.7 | 165,153 | Class A Common Stock |
Nuvation Bio Inc - Ordinar... | Robert Mashal | Director | Purchase of securities on an exchange or from another person at price $ 1.67 per share. | 01 Apr 2025 | 1,100 | 101,100 | - | 1.7 | 1,832 | Class A Common Stock |
Nuvation Bio Inc - Ordinar... | Robert Mashal | Director | Purchase of securities on an exchange or from another person at price $ 2.20 per share. | 08 Oct 2024 | 99,981 | 100,000 | - | 2.2 | 219,958 | Class A Common Stock |
Nuvation Bio Inc - Ordinar... | Robert Mashal | Director | Purchase of securities on an exchange or from another person at price $ 2.21 per share. | 08 Oct 2024 | 19 | 19 | - | 2.2 | 42 | Class A Common Stock |
Nuvation Bio Inc - Ordinar... | Robert Mashal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2024 | 741,179 | 741,179 | - | - | Stock Option (Right to Buy) |